Pliant Therapeutics, Inc. Being Investigated on Behalf of Pliant Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
GEN9h
Study Shows Anti-Aging Potential for Insilico’s IPF Candidate
ISM001-055 was shown to have attenuated cellular senescence through the suppression of various aging processes, thus showing potential as a senomorphic drug.
48 hills20h
Under the Stars: Time to pull out the big baÄŸlama
Hey it’s Under The Stars, your weekly rundown of what is popping in The Bay and beyond. A column that presents new music ...
pulmonaryfibrosisnews2h
Runx2 protein may be treatment target for pulmonary fibrosis
A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows.